Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial

Autor: Anne Dubois, Jean-Jacques Tuech, Philippe Rouanet, M. Bertrand, Anne Rullier, Marc Pocard, Quentin Denost, Véronique Vendrely, Bertrand Trilling, Mehrdad Jafari, Alain Valverde, G. Portier, Cécile de Chaisemartin, Nora Frulio, Julien Asselineau, Eric Frison, Denis Smith, Eric Rullier, Bernard Meunier, Michel Rivoire, Igor Sieleznieff, Frédéric Marchal

Publikováno v: The Lancet Gastroenterology and Hepatology
The Lancet Gastroenterology and Hepatology, Elsevier, 2020, 5 (5), pp.465-474. ⟨10.1016/S2468-1253(19)30410-8⟩
The Lancet Gastroenterology & Hepatology
The Lancet Gastroenterology & Hepatology, 2020, 5 (5), pp.465-474. ⟨10.1016/S2468-1253(19)30410-8⟩

Summary Background GRECCAR 2 was the first multicentre, randomised trial to compare local excision with total mesorectal excision in downstaged low rectal cancer. Encouraging oncological results were noted at 3 years' follow-up but needed to be corro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06f8da1081b07e9eba901accb3a0227c
https://hal.umontpellier.fr/hal-03350581

Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer

Autor: Philippe Morice, Jean Pierre Malhaire, Annie Rey, Guillaume Magnin, Pascale Romestaing, Gilles Houvenaeghel, Patrice Mathevet, Didier Cowen, Jean Lévêque, Christine Haie-Meder, Eric Fondrinier, Philippe Rouanet, Jocelyne Berille, Jean Charles Boulanger

Publikováno v: Oncologist
Oncologist, AlphaMed Press, 2012, 17 (1), pp.64-71. ⟨10.1634/theoncologist.2011-0276⟩
Oncologist, 2012, 17 (1), pp.64-71. ⟨10.1634/theoncologist.2011-0276⟩

Learning Objectives After completing this course, the reader will be able to: Evaluate the therapeutic impact of hysterectomy after chemoradiation therapy in locally advanced cervical cancer.Evaluate the rate of histologic residual disease in patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbc4eb293b159fc58d916a9bd4694009
https://hal.archives-ouvertes.fr/hal-00873869